The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 24, 2017
Filed:
Mar. 04, 2013
Applicant:
Board of Regents, the University of Texas System, Austin, TX (US);
Inventors:
Ashish M. Kamat, Houston, TX (US);
Joseph Briggman, Westford, MA (US);
Colin P. Dinney, Houston, TX (US);
Diana Urbauer, Houston, TX (US);
Assignee:
Board of Regents, The University of Texas System, Austin, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/574 (2006.01); A61K 35/74 (2015.01); A61N 5/10 (2006.01); G06F 19/00 (2011.01);
U.S. Cl.
CPC ...
G01N 33/57488 (2013.01); A61K 35/74 (2013.01); A61N 5/10 (2013.01); G01N 33/57407 (2013.01); G06F 19/3487 (2013.01); G01N 2333/52 (2013.01); G01N 2333/54 (2013.01); G01N 2333/545 (2013.01); G01N 2333/5412 (2013.01); G01N 2333/5434 (2013.01); G01N 2333/57 (2013.01); G01N 2333/70575 (2013.01); G01N 2800/52 (2013.01);
Abstract
Methods for predicting cancer recurrence following a BCG immunotherapy are provided. In some aspects, cytokine levels from a patient are measured before and after a BCG therapy and the changes in cytokine levels are used to determine the risk of cancer lapse. Methods for selecting a patient for a further anti-cancer therapy are also provided.